0001214659-24-004306.txt : 20240311
0001214659-24-004306.hdr.sgml : 20240311
20240311103552
ACCESSION NUMBER: 0001214659-24-004306
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240307
FILED AS OF DATE: 20240311
DATE AS OF CHANGE: 20240311
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kraus Carl N
CENTRAL INDEX KEY: 0001946475
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38599
FILM NUMBER: 24736925
MAIL ADDRESS:
STREET 1: C/O ACERAGEN, INC.
STREET 2: 15 TW ALEXANDER DRIVE
CITY: DURHAM
STATE: NC
ZIP: 27709
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aquestive Therapeutics, Inc.
CENTRAL INDEX KEY: 0001398733
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 208623253
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 30 TECHNOLOGY DRIVE
CITY: WARREN
STATE: NJ
ZIP: 07059
BUSINESS PHONE: 908-941-1900
MAIL ADDRESS:
STREET 1: 30 TECHNOLOGY DRIVE
CITY: WARREN
STATE: NJ
ZIP: 07059
FORMER COMPANY:
FORMER CONFORMED NAME: MonoSol Rx, Inc.
DATE OF NAME CHANGE: 20070507
4
1
marketforms-64692.xml
PRIMARY DOCUMENT
X0508
4
2024-03-07
0001398733
Aquestive Therapeutics, Inc.
AQST
0001946475
Kraus Carl N
C/O AQUESTIVE THERAPEUTICS, INC.
30 TECHNOLOGY DRIVE
WARREN
NJ
07059
false
true
false
false
Chief Medical Officer
0
Common Stock
2024-03-07
4
A
false
112500
0
A
262500
D
Non-Qualified Stock Option (right to buy)
5.68
2024-03-07
4
A
false
56250
0
A
2034-03-07
Common Stock
56250
56250
D
The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment
The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.
/s/ Lori Braender, as Attorney-In-Fact
2024-03-11